High incidence of non-tuberculous mycobacteria-positive cultures among adolescent with cystic fibrosis

Journal of Cystic Fibrosis

Volumn 16, Issue 5, 2017, Pages 579-584

  Cavalli, Zoé ^a,b   Reynaud, Quitterie ^a,b   Bricca, Romain ^a,b   Nove Josserand, Raphaële ^a   Durupt, Stéphane ^a   Reix, Philippe ^a,b   Perceval, Marie ^a   de Montclos, Michèle Pérouse ^a,b   Lina, Gérard ^a,b   Durieu, Isabelle ^a,b  

^a HOSPICES CIVILS DE LYON   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

Cystic fibrosis; Mycobacterium abscessus; Mycobacterium avium; Non tuberculous mycobacteria; Pulmonary disease

Indexed keywords

CORTICOSTEROID; ITRACONAZOLE;

ADOLESCENT; ADULT; ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ARTICLE; ATYPICAL MYCOBACTERIUM; BACTERIUM CULTURE; BACTERIUM ISOLATE; CASE CONTROL STUDY; CHILD; CLINICAL ARTICLE; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTIC FIBROSIS; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FRANCE; GROUPS BY AGE; HUMAN; INCIDENCE; LONGITUDINAL STUDY; LUNG DISEASE; LUNG FUNCTION; MALE; MASS SPECTROMETER; MULTIVARIATE ANALYSIS; MYCOBACTERIUM AVIUM COMPLEX; PERSISTENT INFECTION; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; STAPHYLOCOCCUS AUREUS; UNIVARIATE ANALYSIS; YOUNG ADULT; ATYPICAL MYCOBACTERIOSIS; COMPLICATION; ISOLATION AND PURIFICATION; LUNG FUNCTION TEST; PATHOPHYSIOLOGY; PROCEDURES; RESPIRATORY TRACT INFECTION; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CYSTIC FIBROSIS; FEMALE; FRANCE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; RESPIRATORY FUNCTION TESTS; RESPIRATORY TRACT INFECTIONS;

EID: 85011958829     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2017.01.017     Document Type: Article

References (31)

1. Qvist, T., Pressler, T., Høiby, N., Katzenstein, T.L., Shifting paradigms of nontuberculous mycobacteria in cystic fibrosis. Respir Res, 15, 2014, 41.
2. Floto, R.A., Olivier, K.N., Saiman, L., Daley, C.L., Herrmann, J.-L., Nick, J.A., et al. US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary. Thorax 71 (2016), 88–90.
3. Bar-On, O., Mussaffi, H., Mei-Zahav, M., Prais, D., Steuer, G., Stafler, P., et al. Increasing nontuberculous mycobacteria infection in cystic fibrosis. J Cyst Fibros 14 (2015), 53–62.
4. Oliver, A., Maiz, L., Cantón, R., Escobar, H., Baquero, F., Gómez-Mampaso, E., Nontuberculous mycobacteria in patients with cystic fibrosis. Clin Infect Dis 32 (2001), 1298–1303.
5. Olivier, K.N., Weber, D.J., Wallace, R.J., Faiz, A.R., Lee, J.-H., Zhang, Y., et al. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 167 (2003), 828–834.
6. Roux, A.-L., Catherinot, E., Ripoll, F., Soismier, N., Macheras, E., Ravilly, S., et al. Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in France. J Clin Microbiol 47 (2009), 4124–4128.
7. Griffith, D.E., Aksamit, T., Brown-Elliott, B.A., Catanzaro, A., Daley, C., Gordin, F., et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175 (2007), 367–416.
8. Coolen, N., Morand, P., Martin, C., Hubert, D., Kanaan, R., Chapron, J., et al. Reduced risk of nontuberculous mycobacteria in cystic fibrosis adults receiving long-term azithromycin. J Cyst Fibros 14 (2015), 594–599.
9. Albrecht, C., Ringshausen, F., Ott, S., Wagner, D., Rademacher, J., Schneider, M., et al. Should all adult cystic fibrosis patients with repeated nontuberculous mycobacteria cultures receive specific treatment? A 10-year case–control study. Eur Respir J, 2016, 10.1183/13993003.01239-2015.
10. Martiniano, S.L., Sontag, M.K., Daley, C.L., Nick, J.A., Sagel, S.D., Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis. Ann Am Thorac Soc 11 (2014), 36–44.
11. Binder, A.M., Adjemian, J., Olivier, K.N., Prevots, D.R., Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis. Am J Respir Crit Care Med 188 (2013), 807–812.
12. Levy, I., Grisaru-Soen, G., Lerner-Geva, L., Kerem, E., Blau, H., Bentur, L., et al. Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel. Emerg Infect Dis 14 (2008), 378–384.
13. Mussaffi, H., Rivlin, J., Shalit, I., Ephros, M., Blau, H., Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy. Eur Respir J 25 (2005), 324–328.
14. Renna, M., Schaffner, C., Brown, K., Shang, S., Tamayo, M.H., Hegyi, K., et al. Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection. J Clin Invest 121 (2011), 3554–3563.
15. Esther, C.R., Esserman, D.A., Gilligan, P., Kerr, A., Noone, P.G., Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis. J Cyst Fibros 9 (2010), 117–123.
16. Esther, C.R., Henry, M.M., Molina, P.L., Leigh, M.W., Nontuberculous mycobacterial infection in young children with cystic fibrosis. Pediatr Pulmonol 40 (2005), 39–44.
17. Qvist, T., Taylor-Robinson, D., Waldmann, E., Olesen, H.V., Hansen, C.R., Mathiesen, I.H., et al. Comparing the harmful effects of nontuberculous mycobacteria and Gram negative bacteria on lung function in patients with cystic fibrosis. J Cyst Fibros 15 (2015), 380–385.
18. Leitritz, L., Griese, M., Roggenkamp, A., Geiger, A.M., Fingerle, V., Heesemann, J., Prospective study on nontuberculous mycobacteria in patients with and without cystic fibrosis. Med Microbiol Immunol 193 (2004), 209–217.
19. Forslöw, U., Geborek, A., Hjelte, L., Petrini, B., Heurlin, N., Early chemotherapy for non-tuberculous mycobacterial infections in patients with cystic fibrosis. Acta Paediatr 92 (2003), 910–915.
20. Société Française de Microbiologie, Infections bronchopulmonaires et mucoviscidose. REMIC Réf. En Microbiol. Médicale. 5ème, 2015, Société Française de Microbiologie, 193–200.
21. Pin, D., Guérin-Faublée, V., Garreau, V., Breysse, F., Dumitrescu, O., Flandrois, J.-P., et al. Mycobacterium species related to M. leprae and M. lepromatosis from cows with bovine nodular thelitis. Emerg Infect Dis 20 (2014), 2111–2114.
22. Clinical and Laboratory Standards Institute, Susceptibility testing of Mycobacteria, Nocardiae, and other aerobic Actinomycetes; approved standard—second edition. 2011.
23. Tillie-Leblond, I., Tonnel, A.-B., Allergic bronchopulmonary aspergillosis. Allergy 60 (2005), 1004–1013.
24. Catherinot, E., Roux, A.-L., Vibet, M.-A., Bellis, G., Ravilly, S., Lemonnier, L., et al. Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations. J Cyst Fibros 12 (2013), 74–80.
25. Qvist, T., Gilljam, M., Jönsson, B., Taylor-Robinson, D., Jensen-Fangel, S., Wang, M., et al. Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia. J Cyst Fibros 14 (2015), 46–52.
26. Adjemian, J., Olivier, K.N., Prevots, D.R., Nontuberculous mycobacteria among patients with cystic fibrosis in the United States: screening practices and environmental risk. Am J Respir Crit Care Med 190 (2014), 581–586.
27. Radhakrishnan, D.K., Yau, Y., Corey, M., Richardson, S., Chedore, P., Jamieson, F., et al. Non-tuberculous mycobacteria in children with cystic fibrosis: isolation, prevalence, and predictors. Pediatr Pulmonol 44 (2009), 1100–1106.
28. Pierre-Audigier, C., Ferroni, A., Sermet-Gaudelus, I., Le Bourgeois, M., Offredo, C., Vu-Thien, H., et al. Age-related prevalence and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis. J Clin Microbiol 43 (2005), 3467–3470.
29. Sermet-Gaudelus, I., Le Bourgeois, M., Pierre-Audigier, C., Offredo, C., Guillemot, D., Halley, S., et al. Mycobacterium abscessus and children with cystic fibrosis. Emerg Infect Dis 9 (2003), 1587–1591.
30. Seddon, P., Fidler, K., Raman, S., Wyatt, H., Ruiz, G., Elston, C., et al. Prevalence of nontuberculous mycobacteria in cystic fibrosis clinics, United Kingdom, 2009. Emerg Infect Dis 19 (2013), 1128–1130.
31. Towle, D., Callan, D.A., Lamprea, C., Murray, T.S., Baby bottle steam sterilizers for disinfecting home nebulizers inoculated with non-tuberculous mycobacteria. J Hosp Infect 92 (2016), 222–225.